Minocycline-induced cutaneous hyperpigmentation.
Joseph
W S
WS
Sabo
M A
MA
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007871:Leg Ulcer / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000009:adverse effects* / Q000627:therapeutic use; D011379:Prognosis; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D008911:Minocycline